MARIA GADDY: Open Payments
NPI 1588033195 · GREENSBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 28 payments from 19 companies in 2025. Trend: 2023 $670 · 2024 $1,515 · 2025 $745
Food & beverage: $632Education: $113
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $101 |
| SEAGEN INC. | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| PFIZER INC. | 3 | $64 |
| ABBVIE INC. | 2 | $61 |
| Janssen Biotech, Inc. | 2 | $50 |
| JAZZ PHARMACEUTICALS INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| BeiGene USA, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $26 |
Products named: Enhertu, LIBTAYO, IMBRUVICA, ZEPZELCA, NINLARO, BRAFTOVI, RYBREVANT, BRUKINSA.
Industry payments across GA — which companies pay providers there.
